Enlicitide Decanoate

N/A

Report date: 2026/05/23 20:00:57

Base Information

Drug NameEnlicitide Decanoate
Drug Alias NameEnlicitide ChlorideMK-0616
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHeterozygous familial hypercholesterolemiaSitosterolemiaHypercholesterolemia +[11
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[34
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHeterozygous familial hypercholesterolemiaSitosterolemiaHypercholesterolemia +[10
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A